Juma Al-Busaidi

Mr. Juma Al-Busaidi


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
Elias A. SaidElias A. Said
Elias A. Said
AAAfnan Al-Rubkhi
Afnan Al-Rubkhi
SJSanjay Jaju
Sanjay Jaju
CKCrystal Y. Koh
Crystal Y. Koh
MAMohammed Said Al-Balushi
Mohammed Said Al-Balushi
AAAli Al-Jabri
Ali Al-Jabri
Vaccination provides the best protection against the increasing infections of SARS-CoV-2. The magnitude and type of anti-SARS-CoV-2 vaccine side effects (SEs) depend on parameters that are not fully understood. In this cross-sectional study, the associations between different anti-SARS-CoV-2 vaccine SEs and age, sex, the presence of chronic diseases, medication intake, history of allergies, and infections with SARS-CoV-2 were investigated. Our survey used the Google platform and had 866 participants, contacted through e-mails, social media and chain referral sampling (margin of error ≈ 4.38%, 99% confidence). More than 99% of the participants received the BNT162b2 and ChAdOx1-S vaccines. Being female, having chronic diseases, taking medicines routinely and the presence of a SARS-CoV-2 infection (p < 0.05) were associated with strong SEs after the BNT162b2 vaccine second dose. Having a history of allergies and a female sex (p < 0.01) were associated with strong SEs after the ChAdOx1-S vaccine second dose. Furthermore, the results reveal, for the first time, the associations between having a history of allergies, chronic diseases, medication usage, and SEs of a strong magnitude for the BNT162b2 and ChAdOx1-S vaccines. Additionally, this study supports the association of the female sex and infection with SARS-CoV-2 with an increased potential of developing stronger SEs with certain anti-SARS-CoV-2 vaccines.

13 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MAMohammed Said Al-Balushi
Mohammed Said Al-Balushi
IAIrin Antony
Irin Antony
AAAli H. Al-Shirawi
Ali H. Al-Shirawi
HAHamad Al-Riyami
Hamad Al-Riyami
JAJuma Al-Busaidi
Juma Al-Busaidi
Elias A. SaidElias A. Said
Elias A. Said
Background/Objectives: Rheumatoid arthritis (RA) is an autoimmune disease that is influenced by polymorphisms in the HLA molecules. Only a few studies assessed the presence of an association between HLA class I genes and RA. Moreover, ethnic background influences the association of HLA molecules and RA. HLA-I molecules are essential for the activation of CD8 T cells and natural killer (NK) cells. The implication of these cells in RA pathogenesis is controversial. Therefore, we investigated the presence of associations between HLA-I alleles and RA in Omani patients. Methods: HLA class I alleles were genotyped in a total of 206 volunteers (102 RA patients and 104 controls). The control group included volunteers who were not affected by any known disease. The Chi square test was used to investigate the significance of the associations between the HLA alleles and the occurrence of RA. A corrected p value (pc) was calculated using the Bonferroni correction. Results: The frequency of HLA-B*58 was ≈2.7-fold lower in RA patients (10.8%) compared to the control group (28.8%; pc = 0.0324). Moreover, the frequency of HLA-C*02 in RA patient was ≈8-fold higher compared to the control group (pc = 0.0104). Conclusions: This study is the first to demonstrate the presence of association between HLA-B*58 and HLA-C*02 and the occurrence of RA, which could guide future research on targeted therapies. It also suggests that these HLA alleles might influence CD8 T cells and NK cells implication in RA pathogenesis.